Cultivation/Fermentation Technique June 2023

Production and analysis of metabolites from solidstate fermentation of Chenopodium formosanum (Djulis) sprouts in a bioreactor

Chen-Che Hsieh , Shu-Han Yu , Hsing-Chun Kuo , Darin Khumsupan , Hsiao-Chu Huang ,
Yu-Wei Liou , Chen-Yu Kao , Szu-Chuan Shen , Kuan-Chen Cheng

Abstract


Fresh fourth-day Chenopodium formosanum sprouts were fermented using Rhizopus oligosporus. Compared to plate fermentation (PF), bioreactor fermentation (BF) at 35 °C with 0.4 vvm aeration and 5 rpm yielded higher antioxidant capacity, peptide content (99.56 ± 7.77 mg/g), and enzyme activity (amylase, glucosidase, proteinase). Mass spectrometry identified two bioactive peptides (TDEYGGSIENRFMN and DNSMLTFEGAPVQGAAAITEK) as potential DPP-IV and ACE inhibitors. Over 20 novel metabolites were found in BF samples. The BF system enhances nutritional and bioactive properties, offering promise for scale-up.

Winpact Model: FS-V-SA05P

Introduction

Chenopodium formosanum, a native pseudocereal in Taiwan, is rich in essential amino acids, phenols, flavonoids, and GABA. Although similar to quinoa, it has superior nutritional value. Solid‑state fermentation with Rhizopus oligosporus may offer a scalable way to enhance its bioactive compound profile. 

Materials and Methods

Fermentation Process:
Fresh fourth-day Chenopodium formosanum sprouts (1.5 kg) were sterilized and inoculated with 75 mL of Rhizopus oligosporus spores at 10^6 spores/mL (5% v/w). Solid‑state fermentation occurred in a bioreactor FSeV‑SA05P (Winpact FS‑V‑SA05P) at 35 °C, with aeration at 0.4 vvm and rotation at 5 rpm, for four days. Free peptide content was quantified as 99.56 ± 7.77 mg casein tryptone equivalent per gram dry substrate.

Enzyme activities measured included amylase (2.21 ± 0.01 U/g), β‑glucosidase (54.57 ± 10.88 U/g), and proteinase (40.81 ± 6.52 U/g). Mass spectrometry was used to identify peptides and metabolites generated by fermentation; two peptides (TDEYGGSIENRFMN and DNSMLTFEGAPVQGAAAITEK) were highlighted as DPP‑IV and ACE inhibitors

Results

  • – Bioreactor fermentation (BF) produced significantly higher free peptide content and enzyme activities compared to plate fermentation (PF).
  • – Identified peptides potentially act as DPP‑IV and ACE inhibitors.
  • – Over twenty new metabolites, including aromatics, amines, fatty acids, and carboxylic acids, were generated specifically in BF.
  • – Enhanced antioxidant capacity was demonstrated in BF-derived products.

References

Production and analysis of metabolites from solid‑state fermentation of Chenopodium formosanum (Djulis) sprouts in a bioreactor
https://doi.org/10.1016/j.foodres.2023.112707